Synthesis and structure–activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor–ligand-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthesis and structure–activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor–ligand

Published:2010-02 Issue:3 Volume:18 Page:1149-1162
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Seo Hee Jeong,Kim Min Ju,Lee Suk Ho,Lee Sung-Han,Jung Myung Eun,Kim Mi-Soon,Ahn Kwangwoo,Kim Jeongmin,Lee Jinhwa

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference34 articles.

1. Current and Investigational Antiobesity Agents and Obesity Therapeutic Treatment Targets

2. The obesity pandemic

3. Obesity: a disease or a biological adaptation?

4. Rimonabant: A novel selective cannabinoid-1 receptor antagonist for treatment of obesity

5. Obesity: The Disease

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Triazole in Medicinal Chemistry: Advancement in Drug Design, Reward and Biological Activity;Chemistry & Biodiversity;2024-06-26

2. Synthesis, relative configuration and CB1 receptor affinity studies for a set of 1,2,3-triazole derivatives;Journal of Molecular Structure;2023-06

3. Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB1R) ?Cis-On? Agonist;ACS CHEM NEUROSCI;2022

4. Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB₁R) “Cis-On” Agonist;ACS Chemical Neuroscience;2022-07-26

5. “Photo-Rimonabant”: Synthesis and Biological Evaluation of Novel Photoswitchable Molecules Derived from Rimonabant Lead to a Highly Selective and Nanomolar “Cis-On” CB1R Antagonist;ACS Chemical Neuroscience;2021-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3